Understanding why weight gain occurs despite treatment requires a comprehensive assessment of medication factors, physiological responses, behavioral patterns, and female-specific considerations
Selection depends on individual factors, including target weight loss, tolerance for side effects, injection frequency preference, and concurrent health conditions
This is a personal decision based on your individual experience
Though VIP can trigger mast-cell degranulation in isolation, within the nervous system, it appears to reprogram mast cells toward a non-degranulating phenotype, offering paradoxical protection rather than harm
The lawsuits against Novo Nordisk, Wegovys manufacturer, hinge on the claim that these risks were underreported or misrepresented in marketing materials and prescribing information
(3) Chiechio, S